
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

Gross Margin
Ouro Fino Saude Animal Participacoes SA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
BR |
![]() |
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
|
1.2B BRL |
51%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
779.4B USD |
81%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
394B USD |
69%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2.1T DKK |
85%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
236.5B CHF |
73%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
177B GBP |
82%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
225.9B USD |
81%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
199.7B CHF |
75%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD |
68%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
142.8B USD |
74%
|
Ouro Fino Saude Animal Participacoes SA
Glance View
Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Ouro Fino Saude Animal Participacoes SA's most recent financial statements, the company has Gross Margin of 50.5%.